Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
Clinical trial NCT02327273 · COMPLETED
Trial details
- NCT number
- NCT02327273
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.